Regulators Mandate Price Reductions for 543 Cancer Drug Brands
Regulators have mandated price cuts for 543 cancer drug brands effective November 9, following a policy to cap trade margins at 30% to improve treatment…

National pharmaceutical regulators have mandated significant price reductions for 543 brands of anti-cancer medications, effective November 9. The policy adjustment follows a government decision to cap trade margins at 30% for 137 non-scheduled anti-cancer drugs, aiming to standardize profit margins and improve patient access to essential treatments.
Market data indicates substantial price decreases across various therapeutic categories, with some medications seeing reductions of up to 90%. Notable adjustments include significant drops in the maximum retail price for injections and tablets used in treating breast, colon, and blood-related cancers.
Industry analysts note that while the policy is intended to lower the financial burden on patients, there are concerns regarding the long-term manufacturing viability of low-cost, life-saving drugs. Regulators maintain that the measure is necessary to curb excessive trade margins and ensure the affordability of critical oncology treatments.
More stories
- Greece targets 2.3% growth in 2027 budget
- US stocks face Goldman warning on further forced selling
- Bitcoin falls below $57,742 as investors seek other bets
- Nvidia SEC probe examines chipmaker’s accounting issues
- Rwanda women-owned exports fall 51% from 2021 peak
- Nasdaq rout tests IPO appetite as Anthropic gains retreat
- EU rules bar Nord Stream return under 2027 gas phaseout
- Investors weigh OpenAI strengths against Anthropic growth
- Anthropic faces $265.6bn purchase commitments in IPO push
- Anthropic faces $800bn compute burden before Nasdaq IPO
Latest news
- Hull City 2–0 Brighton: When Resilience Beat Reputation
- David Parr House to honor Victorian art-workman with blue plaque
- Iran's attacks hit 25 tankers near Strait of Hormuz
- FCC approves prison cellphone jamming despite 2.5-mile warning
- Russia strikes Ukraine as Odesa faces electricity strain
- Bahrain reports two injuries after Iranian aerial attacks
- Congress tests Black Democrats' growing policy influence
- Baltic responders fight Sparta II fire after drone strike

